The big news in David Systrom’s “Neurovascular Dysregulation Underlies Exercise Intolerance in ME/CFS” talk at the CDC yesterday was that the $8 million mitochondrial drug trial had, unfortunately, failed. The ME/CFS Mitochondrial Drug Trial Fails...
A rough winter awaits. Did we relax our vigilance too soon? Eric Topol started off his latest article, “The new COVID wave”, stating “Things are once again going in the wrong direction in the United States.” (What else is new?) Walk into a...
This University of Colorado/ National Jewish Health Center study, “Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC)”, follows on the heels of another study...
From the beginning, the RECOVER Initiative has focused on building out the massive infrastructure needed to follow and study approximately 18,000 participants. Hundreds of millions of dollars have been spent creating the main thrust of the Initiative. About a year...
Veteran’s Administration Joins the Long-COVID Fray A new long-COVID preprint that recently came out just screams that times have changed. For one thing – the study is huge – 9,000 patients! It also shows long COVID has made it into the...
What a timely meeting. Mass ME/CFS and FM was celebrating its 40th anniversary, and so probably was Tony Komaroff MD and his long history of treating, researching, and advocating for chronic fatigue syndrome (ME/CFS) – we are facing the most exciting and...
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.